Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Feb;31(1):230-46.
doi: 10.1007/s10637-012-9873-z. Epub 2012 Aug 31.

Development of artemisinin compounds for cancer treatment

Henry C Lai  1 , Narendra P Singh, Tomikazu Sasaki
Affiliations
Review

Development of artemisinin compounds for cancer treatment

Henry C Lai et al. Invest New Drugs. 2013 Feb.

Abstract

Artemisinin contains an endoperoxide moiety that can react with iron to form cytotoxic free radicals. Cancer cells contain significantly more intracellular free iron than normal cells and it has been shown that artemisinin and its analogs selectively cause apoptosis in many cancer cell lines. In addition, artemisinin compounds have been shown to have anti-angiogenic, anti-inflammatory, anti-metastasis, and growth inhibition effects. These properties make artemisinin compounds attractive cancer chemotherapeutic drug candidates. However, simple artemisinin analogs are less potent than traditional cancer chemotherapeutic agents and have short plasma half-lives, and would require high dosage and frequent administration to be effective for cancer treatment. More potent and target-selective artemisinin-compounds are being developed. These include artemisinin dimers and trimers, artemisinin hybrid compounds, and tagging of artemisinin compounds to molecules that are involved in the intracellular iron-delivery mechanism. These compounds are promising potent anticancer compounds that produce significantly less side effect than traditional chemotherapeutic agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rheumatology (Oxford). 2007 Jun;46(6):920-6 - PubMed
    1. Int Immunopharmacol. 2008 Dec 20;8(13-14):1744-7 - PubMed
    1. J Med Chem. 2009 Feb 26;52(4):1198-203 - PubMed
    1. J Nat Prod. 1993 Jun;56(6):849-56 - PubMed
    1. Biochem Pharmacol. 2004 Dec 15;68(12):2359-66 - PubMed

Publication types

LinkOut - more resources